Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.
A novel interleukin-2 (IL-2)-dependent T-cell line, WHN2, was established from a patient with adult T-cell leukemia (ATL) not associated with human T-cell leukemia virus type I (HTLV-I). Neither the original leukemic cells nor the WHN2 cells showed proviral integration in their cellular DNAs by Southern blot analysis. The surface phenotype showed that both the original leukemic cells and the WHN2 cells had a common phenotype of ATL, i.e., positive for CD2, CD4, human leukocyte antigen DR (HLA-DR) and CD25, but negative for CD8, a characteristic of helper/inducer T-cells. Most of the chromosomal abnormalities of the original leukemic cells were maintained in the WHN2 cell line. Furthermore, Southern blot analysis of the T-cell receptor beta-chain gene rearrangement revealed that the original leukemic cells and WHN2 cell line had identical patterns, suggesting that the WHN2 cell line was truly derived from the original leukemic cells. Dose-dependent growth on IL-2 was demonstrated, and at the maximal stimulation, the number of cells doubled within three days. This IL-2-dependent growth was inhibited by the simultaneous existence of anti-IL-2 receptor alpha and beta chain antibodies. These results indicate that the character of the WHN2 cell line is similar to that of the cell lines derived from ATL associated with HTLV-I. Thus, the HTLV-I-negative ATL cell line, WHN2, should be useful in the comparative study of the pathogenesis of ATL associated with or without HTLV-I.
Department of Hematology and Chemotherapy, Aichi Cancer Center, Nagoya.
Y
Y
Kagami
K
K
Tobinai
T
T
Kinoshita
H
H
Nagai
T
T
Hotta
M
M
Seto
R
R
Ueda
H
H
Saito
D000368:Aged; D000906:Antibodies / Q000494:pharmacology; D000954:Antigens, Surface / Q000032:analysis; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D004279:DNA, Viral / Q000032:analysis; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor / Q000235:genetics; D015368:Human T-lymphotropic virus 1 / Q000235:genetics; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007621:Karyotyping; D015458:Leukemia, T-Cell / Q000097:blood* / Q000235:genetics / Q000382:microbiology; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000097:blood* / Q000235:genetics / Q000382:microbiology; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008297:Male; D008969:Molecular Sequence Data; D010641:Phenotype; D011533:Proviruses / Q000235:genetics; D015375:Receptors, Interleukin-2 / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000473:pathology* / Q000502:physiology; D014407:Tumor Cells, Cultured
D000906:Antibodies; D000954:Antigens, Surface; D004279:DNA, Viral; D007376:Interleukin-2; D015375:Receptors, Interleukin-2